Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07671937 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

INtegrating Systematic PatIent-Reported Evaluations in Multi-Disciplinary Tumor Boards: The INSPIRE Study

Study acronym: INSPIRE
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Start date changed from estimate of Sep 1, 2026 to Oct 2, 2026 · Eligibility criteria expanded, about 9 words · Site details revised at 3 of 3 sites Show 3 more changesShow less
    • Start date changed from estimate of Sep 1, 2026 to Oct 2, 2026
    • Eligibility criteria expanded, about 9 words
    • Site details revised at 3 of 3 sites
  2. Site contacts updated at 1 of 3 sitesv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to characterize baseline multidisciplinary tumor board (MDTB) context and variability, evaluate the relationship between baseline fitness of patients with cancer and initial treatment recommendations, and assess the impact of the INSPIRE intervention, which involves including electronic patient reported outcomes (ePROs) within MDTB on MDTB discussion content, provider burden, treatment recommended and received, healthcare utilization, and patient-reported outcomes.
Trial Details
NCT Number NCT07671937
Lead Sponsor University of Alabama at Birmingham
Collaborators: University of Oklahoma, University of California, Los Angeles, Canopy Cancer Collective, LLC
Conditions Breast Cancer, Corpus Uteri Cancer, Ovary Cancer, Pancreas Cancer, Other Female Genital Malignant Neoplasms
Enrollment 2,748 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov